These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2668698)

  • 21. Cardiorenal actions of endothelin, Part I: Effects of converting enzyme inhibition.
    Cao LQ; Banks RO
    Life Sci; 1990; 46(8):577-83. PubMed ID: 2407919
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cross tachyphylaxis to endothelin isopeptide-induced hypotension: a phenomenon not seen with proendothelin.
    Le Monnier de Gouville AC; Cavero I
    Br J Pharmacol; 1991 Sep; 104(1):77-84. PubMed ID: 1786522
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of nifedipine to prevent systemic and renal vasoconstrictor effects of endothelin.
    Madeddu P; Yang XP; Anania V; Troffa C; Pazzola A; Soro A; Manunta P; Tonolo G; Demontis MP; Varoni MV
    Am J Physiol; 1990 Aug; 259(2 Pt 2):F304-11. PubMed ID: 2201205
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the effects of endothelin-1 and endothelin-3 on the rat stomach.
    Wallace JL; Keenan CM; MacNaughton WK; McKnight GW
    Eur J Pharmacol; 1989 Aug; 167(1):41-7. PubMed ID: 2673803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regional haemodynamic effects of endothelin-1 and endothelin-3 in conscious Long Evans and Brattleboro rats.
    Gardiner SM; Compton AM; Bennett T
    Br J Pharmacol; 1990 Jan; 99(1):107-12. PubMed ID: 2139584
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Putative precursors of endothelin have less vasoconstrictor activity in vitro but a potent pressor effect in vivo.
    Kashiwabara T; Inagaki Y; Ohta H; Iwamatsu A; Nomizu M; Morita A; Nishikori K
    FEBS Lett; 1989 Apr; 247(1):73-6. PubMed ID: 2651162
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Calcitonin gene-related peptide is a depressor in subtotal nephrectomy hypertension.
    Supowit SC; Zhao H; Hallman DM; DiPette DJ
    Hypertension; 1998 Jan; 31(1 Pt 2):391-6. PubMed ID: 9453334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hemodynamic effect of human and rat endothelin administration into conscious rats.
    Mortensen LH; Fink GD
    Am J Physiol; 1990 Feb; 258(2 Pt 2):H362-8. PubMed ID: 2178445
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of endothelin-1 on vascular permeability in the conscious rat: interactions with platelet-activating factor.
    Filep JG; Sirois MG; Rousseau A; Fournier A; Sirois P
    Br J Pharmacol; 1991 Dec; 104(4):797-804. PubMed ID: 1667286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic clearance rates of oxyntomodulin and glucagon in the rat: contribution of the kidney.
    Kervran A; Dubrasquet M; Blache P; Martinez J; Bataille D
    Regul Pept; 1990 Oct; 31(1):41-52. PubMed ID: 2270317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of endothelin on cortical microvascular perfusion in rats.
    Willette RN; Sauermelch C; Ezekiel M; Feuerstein G; Ohlstein EH
    Stroke; 1990 Mar; 21(3):451-8. PubMed ID: 2408198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary structure, synthesis, and biological activity of rat endothelin, an endothelium-derived vasoconstrictor peptide.
    Yanagisawa M; Inoue A; Ishikawa T; Kasuya Y; Kimura S; Kumagaye S; Nakajima K; Watanabe TX; Sakakibara S; Goto K
    Proc Natl Acad Sci U S A; 1988 Sep; 85(18):6964-7. PubMed ID: 3045827
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of endothelin on renal function in dogs and rats.
    Banks RO
    Am J Physiol; 1990 Apr; 258(4 Pt 2):F775-80. PubMed ID: 2184673
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies with endothelin-3 and endothelin-1 on rat blood pressure and isolated tissues: evidence for multiple endothelin receptor subtypes.
    Spokes RA; Ghatei MA; Bloom SR
    J Cardiovasc Pharmacol; 1989; 13 Suppl 5():S191-2. PubMed ID: 2473307
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vascular activities of endothelin-1 and some alanyl substituted analogues in resistance beds of the rat.
    Randall MD; Douglas SA; Hiley CR
    Br J Pharmacol; 1989 Oct; 98(2):685-99. PubMed ID: 2684315
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endothelin-1-induced myocardial ischaemia and oedema in the rat: involvement of the ETA receptor, platelet-activating factor and thromboxane A2.
    Filep JG; Fournier A; Földes-Filep E
    Br J Pharmacol; 1994 Jul; 112(3):963-71. PubMed ID: 7921626
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic hypertension produced by infusion of endothelin in rats.
    Mortensen LH; Pawloski CM; Kanagy NL; Fink GD
    Hypertension; 1990 Jun; 15(6 Pt 2):729-33. PubMed ID: 2190924
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endothelium-dependent vascular activities of endothelin-like peptides in the isolated superior mesenteric arterial bed of the rat.
    Douglas SA; Hiley CR
    Br J Pharmacol; 1990 Sep; 101(1):81-8. PubMed ID: 2282471
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hemodynamic effects of endothelin in conscious rats.
    Hinojosa-Laborde C; Osborn JW; Cowley AW
    Am J Physiol; 1989 Jun; 256(6 Pt 2):H1742-6. PubMed ID: 2660597
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radioimmunoassay evidence that the pressor effect of big endothelin-1 is due to local conversion to endothelin-1.
    Corder R; Vane JR
    Biochem Pharmacol; 1995 Jan; 49(3):375-80. PubMed ID: 7857324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.